Surgepays is trading at $0.24, down 10.62%, with its delayed Form 10-Q remaining a potential investor-overhang issue.
- No new company-specific announcement, filing, earnings update, or direct catalyst was identified for August 19, 2026.
- The filing delay, submitted through a Form 12b-25 notice on August 17, 2026, relates to completing financial statements and auditor review.
- The decline is occurring despite broader U.S. indexes trading higher, so the specific cause remains unclear.